GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Rashi Peripherals Ltd

Rashi Peripherals to Consider Q2 FY27 Results, Fundraise, and Capital Increase

RESULTS ◆ Monitor Closely MEDIUM RISK
📅 Filed on BSE: 02 Nov 2026, 11:48 AM IST  ·  BSE ID: b6ce10a2-6a1e-4813-acd1-344b9e565a39
View Original BSE Filing (PDF)
💡
In Simple Terms
Rashi Peripherals will announce its latest financial results, consider increasing its capital, and explore options to raise money.
🤖 AI Summary
  • Rashi Peripherals Board meeting scheduled for November 5, 2026, to approve Q2 FY27 unaudited financial results.
  • Company proposes to increase its Authorised Share Capital, requiring Board and shareholder approvals.
  • Board will evaluate proposals for raising funds through various instruments, including equity shares and QIPs.
  • Trading window for Rashi Peripherals securities closed from October 1, 2026, until 48 hours post results.
  • Meeting will cover both standalone and consolidated financial results for the quarter and half year ended September 30, 2026.
🏢 How This Affects the Company
💰
Financial Impact
Considering an increase in Authorised Share Capital and evaluating fund-raising options could provide capital for future growth initiatives or debt reduction, altering the company's financial structure.
⚠️
Risk Impact
Fund-raising proposals could lead to potential equity dilution depending on the chosen instruments and terms of issuance.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this intimation; actions may arise following the Board meeting decisions.
👤
Who Is Affected
All existing shareholders could be affected if fund-raising involves equity issuance, potentially leading to dilution, or if the increased Authorised Share Capital is utilized for future issuances.
🔍
Management Signal
Management signals an intent to potentially strengthen the company's capital base and explore avenues for funding future growth or operational needs.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Board Meeting Outcome on November 5, 2026 — details on Q2 FY27 financial results.
Announcement of Authorised Share Capital increase approval and fund-raising specifics.
Shareholder meeting details if approval is sought for capital increase or fund-raising.
MEDIUM RISK Proposals for fund-raising could introduce equity dilution for existing shareholders, depending on the chosen method.
💡 Investor Takeaway
Rashi Peripherals Board will consider Q2 FY27 standalone and consolidated unaudited financial results on November 5, 2026. Concurrently, the Board will discuss increasing Authorised Share Capital and evaluate fund-raising options, which could include equity shares or QIPs.
📅 Company Track Record
Rashi Peripherals reported Q1 FY27 Net Profit of INR 1,046 million, marking a 69.5% YoY increase. The Board previously approved a ₹150 Cr investment limit for a new joint venture with Japan's Restar, indicating ongoing strategic growth initiatives.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
When is the Rashi Peripherals Board meeting scheduled?
The meeting of the Board of Directors of Rashi Peripherals Limited is scheduled for Thursday, November 5, 2026.
What financial period will be considered at the Rashi Peripherals Board meeting?
The Board will consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2026 (Q2 FY27).
What other business matters will Rashi Peripherals' Board consider?
The Board will consider increasing Authorised Share Capital and evaluating proposals for raising funds via instruments like equity shares, preference shares, debentures, or QIPs.
When is the trading window closed for Rashi Peripherals securities?
The trading window for Rashi Peripherals securities closed from Thursday, October 1, 2026, and will remain closed until 48 hours from the declaration of the financial results.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.